Approved
consistent with clarification in FDA memo of 11-19-02 including
plans to allow electronic submission by March 2003. If any changes
are necessary to the collection as a result of electronic
submission, FDA will submit them to OMB with a change
worksheet.
Inventory as of this Action
Requested
Previously Approved
12/31/2005
12/31/2005
12/31/2002
2,015
0
5,582
987
0
1,662
0
0
0
Cosmetic product ingredient data, when
correlated with cosmetic adverse reaction data, gives FDA
compliance personnel and scientists valuable insight into
potentially unsafe cosmetic formulations, thereby improving FDA's
ability to accomplish its mission to protect the public health by
protecting consumers from injuries resulting from harmful
ingredients in cosmetics.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.